- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/74 - Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
Patent holdings for IPC class C07D 233/74
Total number of patents in this class: 80
10-year publication summary
7
|
6
|
10
|
8
|
7
|
8
|
8
|
3
|
3
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cv6 Therapeutics (NI) Limited | 32 |
10 |
Bayer Cropscience AG | 2035 |
3 |
Technion Research & Development Foundation Ltd. | 1217 |
3 |
University of South Alabama | 125 |
3 |
Foresee Pharmaceuticals USA Inc., DBA Foresee Pharmaceuticals Co. Ltd. | 23 |
3 |
The Regents of the University of California | 19918 |
2 |
The Board of Trustees of the University of Illinois | 2688 |
2 |
University of South Florida | 1826 |
2 |
Endorecherche, Inc. | 23 |
2 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 946 |
2 |
The Scripps Research Institute | 1346 |
2 |
Sanofi | 4055 |
2 |
F. Hoffmann-La Roche AG | 7925 |
1 |
Hoffmann-La Roche Inc. | 3418 |
1 |
Abbott Laboratories | 2399 |
1 |
Hewlett-Packard Development Company, L.P. | 25895 |
1 |
Sumitomo Chemical Company, Limited | 9046 |
1 |
Shin-Etsu Chemical Co., Ltd. | 5658 |
1 |
DSM IP Assets B.V. | 5591 |
1 |
Abbvie Inc. | 1800 |
1 |
Other owners | 36 |